Peter Greenleaf reports a stock award at Altimmune
By AlphaYouPublished Form 4
Greenleaf Peter
Reporting filer
Peter Greenleaf reports a stock award, not an open-market purchase or sale, in Altimmune, Inc.. Form 4 filed Nov 4, 2026 lists 1 entry.
- Disclosed
- Nov 4, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Stock Options (option to buy) (derivative) | Greenleaf Peter | 2026-11-02 | A | Grant or award | 160000 | 0 | 160,000 | 2 days | Filed terms
|
Stock Options (option to buy) (derivative)
- Owner
- Greenleaf Peter
- Date
- 2026-11-02
- Code
- A
- Action
- Grant or award
- Quantity
- 160000
- Price
- 0
- Following holdings
- 160,000
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Stock Options (option to buy)
- conversion Or Exercise Price: 2.02
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: 0
- transaction Shares: 160000
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F1
- expiration Date: 2036-11-02
- underlying Security Title: Common Stock, par value $0.0001
- underlying Security Shares: 160000
- shares Owned Following Transaction: 160000
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Greenleaf Peter: Director.
- F1: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 36 months following November 2, 2026, subject to the reporting person's continued service through the applicable vesting date.
Original sources
Prepared automatically from public filing data. Report a correction.